ORTHO ACEON (PERINDOPRIL ERBUMINE) IS NINTH ANGIOTENSIN- CONVERTING ENZYME INHIBITOR CLEARED FOR U.S. MARKETING; ANTIHYPERTENSIVE APPROVED BY FDA DEC. 30
Executive Summary
Ortho's angiotensin-converting enzyme inhibitor Aceon (perindopril erbumine) is the ninth drug in its class to be approved for marketing in the U.S. and the sixth labeled for once- daily treatment of hypertension.